M&A Deal Summary

Spire Healthcare Acquires Vita

On October 19, 2023, Spire Healthcare acquired healthcare services company Vita from ArchiMed for 74M GBP

Acquisition Highlights
  • This is Spire Healthcare’s 1st transaction in the Healthcare Services sector.
  • This is Spire Healthcare’s 0th largest (disclosed) transaction.
  • This is Spire Healthcare’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2023-10-19
Target Vita
Sector Healthcare Services
Buyer(s) Spire Healthcare
Sellers(s) ArchiMed
Deal Type Add-on Acquisition
Deal Value 74M GBP

Target

Vita

Bury Saint Edmunds, United Kingdom
Vita is a provider of mental and physical health services. Vita provides a range of NHS outpatient mental health talking therapies, musculoskeletal and dermatology services, with operational hubs in London and four regional centres in Bristol, Orpington, Oldham and Leicestershire. Vita also offers outsourced physiotherapy and counselling services to the corporate and occupational health markets. Vita’s services address two of the top causes of illness in the UK. Vita treats mild to moderate mental health conditions such as anxiety and depression. Vita was founded in 1987 and is based in Bury Saint Edmunds, England.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Spire Healthcare

London, United Kingdom
Category Company
Sector Healthcare Services
Employees7,600
DESCRIPTION

Spire Healthcare is a provider of private healthcare, with 37 private hospitals throughout the UK. The company is built on a proud heritage of over 25 years experience of running successful private hospitals. Spire Healthcare is committed to the highest quality of patient care and has earned a reputation as a leader in its field. We were the first private hospital provider to publish outcomes data on our website and we have received numerous awards for our clinical quality, financial performance and leadership, as well as our environmental policy.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (United Kingdom) 1 of 1
Year (2023) 1 of 1

Seller(S) 1

SELLER

ArchiMed

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 8.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.

DEAL STATS #
Overall 9 of 9
Sector (Healthcare Services) 3 of 3
Type (Add-on Acquisition) 8 of 8
Country (United Kingdom) 1 of 1
Year (2023) 2 of 2
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-03-31 Polyplus

Illkirch, France

Polyplus is a biotechnology company that supports Gene and Cell therapy, biologics manufacturing, and life science research with innovative nucleic acid transfection solutions. Polyplus was founded in 2001 and is based in Illkirch, France.

Sell €2.4B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-11-17 Symbio Proinnovera

Jefferson, New York, United States

Symbio Proinnovera is a full-service clinical trial CRO offering for dermatology, complemented by a business active in the pre-clinical formulation of topicals, providing its client’s dermatology and aesthetics services – from pre-clinical formulation work to subsequent clinical trial execution. Symbio Proinnovera is based in Jefferson, New York.

Buy -
Mergr

Product

Company

Legal